US2004192775A1PendingUtilityA1
Alpha-ketoglutarates of active ingredients and compositions containing same
Priority: Jul 25, 2001Filed: Oct 29, 2001Published: Sep 30, 2004
Est. expiryJul 25, 2021(expired)· nominal 20-yr term from priority
Inventors:Pietro Pola
A61P 9/00A61P 7/00A61P 25/00A23L 33/175C07C 229/22A23V 2002/00
36
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Novel stable and pharmacologically acceptable salts of L-carnitine and lower alkanoyl L-carnitines with alpha-ketoglutaric acid are disclosed as well as the compositions useful as dietary and dietetic supplements, nutraceuticals or drugs containing same.
Claims
exact text as granted — not AI-modified1 . L-carnitine and lower alkanoyl L-carnitine alpha-ketoglutarate of formula
wherein:
A − is the alpha-ketoglutarate anion; and
R is hydrogen or a straight- or branched-chain lower alkanoyl having 2-5 carbon atoms.
2 . The alpha-ketoglutarate of claim 1 , wherein R is an alkanoyl selected from the group consisting of acetyl, propionyl, valeryl and isovaleryl.
3 . L-carnitine alpha-ketoglutarate.
4 . Acetyl L-carnitine alpha-ketoglutarate.
5 . Propionyl L-carnitine alpha-ketoglutarate.
6 . Valeryl L-carnitine alpha-ketoglutarate.
7 . Isovaleryl L-carnitine alpha-ketoglutarate.
8 . An orally parenterally or sublingually administrable composition comprising:
(a) an L-carnitine or a lower alkanoyl L-carnitine alpha-ketoglutarate of formula: wherein:
A − is the alpha-ketoglutarate anion; and
R is hydrogen or a straight- or branched-chain lower alkanoyl having 2-5 carbon atoms; and
(b) a pharmacologically acceptable excipient.
9 . The composition of claim 8 , wherein the alpha-ketoglutarate is selected from the group consisting of:
L-carnitine alpha-ketoglutarate; acetyl L-carnitine alpha-ketoglutarate; propionyl L-carnitine alpha-ketoglutarate; valeryl L-carnitine alpha-ketoglutarate; and isovaleryl L-carnitine alpha-ketoglutarate.
10 . The composition of claims 8 or 9 as a pharmaceutical composition, OTC composition, nutritional supplement, dietary supplement, health food, nutraceutical, veterinary product or fodder.
11 . The composition of any one of claims 8 - 10 which further comprises nutritional or pharmacological active ingredients, fillers, binders, lubricants, mold-release agents, flow-regulating agents, dispersing agents, colorants and flavoring agents.
12 . The composition of claim 11 wherein the further nutritional or pharmacological active ingredients are selected from vitamins, amino acids, proteins mineral salts antioxidants and coenzymes.
13 . The composition of any one of claims 8 - 12 in the form of tablets, chewable tablets, pills, troches, lozenges, capsules, powders, granulates, phials, solutions, elixirs or drops.
14 . The composition of any one of claims 8 - 13 , in unit dosage form, comprising an amount of a ketoglutarate of claims 1 - 7 corresponding to about 50-1000 mg, preferably about 100-500 mg, of L-carnitine or alkanoyl L-carnitine as inner salts.
15 . The composition of claim 14 , comprising:
L-carnitine alpha-ketoglutarate
mg
500
Cocarboxylase
mg
2
Vit. B 6
mg
5
Vit. E
mg
5
Vit. PP
mg
20
Vit. C
mg
50
Coenzyme Q 10
mg
25
Selenomethionine
μg
50
Magnesium
mg
25
Calcium
mg
25
Zinc
mg
3
16 . The composition of claim 14 , comprising:
L-carnitine alpha-ketoglutarate
mg
200
Acetyl L-carnitine alpha-ketoglutarate
mg
200
Propionyl L-carnitine alpha-ketoglutarate
mg
200
Cocarboxylase
mg
2
Vit. B 6
mg
5
Vit. E
mg
5
Vit. PP
mg
20
Vit. C
mg
50
Coenzyme Q 10
mg
25
Selenomethionine
μg
50
Magnesium
mg
25
Calcium
mg
25
Zinc
mg
3
17 . Use of an alpha-ketoglutarate of claims 1 - 7 for preparing an orally, parenterally or sublingually administrable composition for the prevention or treatment of organic or tissue disorders brought about by anoxia or inadequate energy supply or metabolic dysfunctions such as those occurring during strenuous physical exercise, in post-infarction states, cardiopathies or neuropathies, in subjects suffering from phenylketonuria and chronic uremic patients undergoing regular haemodialytic treatment.Join the waitlist — get patent alerts
Track US2004192775A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.